ZB
IDXX icon

Zions Bancorporation’s Idexx Laboratories IDXX Stock Holding History

Zions Bancorporation’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$26K Hold
63
– – ﹤0.01% 477
2024
Q3 		$31.8K Sell
63
-433
-87% -$210K ﹤0.01% 469
2024
Q2 		$242K Buy
496
+31
+7% +$15.6K 0.02% 306
2024
Q1 		$251K Sell
465
-6
-1% -$3.28K 0.02% 306
2023
Q4 		$261K Sell
471
-98
-17% -$46K 0.02% 295
2023
Q3 		$249K Buy
569
+91
+19% +$45.4K 0.02% 289
2023
Q2 		$240K Sell
478
-1
-0.2% -$479 0.02% 296
2023
Q1 		$240K Sell
479
-376
-44% -$180K 0.02% 296
2022
Q4 		$349K Buy
855
+178
+26% +$69.1K 0.03% 273
2022
Q3 		$221K Buy
677
+129
+24% +$47.4K 0.02% 297
2022
Q2 		$192K Buy
548
+63
+13% +$25.7K 0.02% 317
2022
Q1 		$265K Buy
485
+412
+564% +$217K 0.02% 298
2021
Q4 		$48K Buy
73
+4
+6% +$2.51K ﹤0.01% 460
2021
Q3 		$43K Buy
69
+49
+245% +$32.9K ﹤0.01% 469
2021
Q2 		$13K Buy
20
+1
+5% +$552 ﹤0.01% 671
2021
Q1 		$9K Sell
19
-18
-49% -$9.02K ﹤0.01% 726
2020
Q4 		$18K Buy
37
+2
+6% +$895 ﹤0.01% 569
2020
Q3 		$14K Hold
35
– – ﹤0.01% 600
2020
Q2 		$12K Hold
35
– – ﹤0.01% 591
2020
Q1 		$8K Hold
35
– – ﹤0.01% 627
2019
Q4 		$9K Hold
35
– – ﹤0.01% 737
2019
Q3 		$10K Hold
35
– – ﹤0.01% 711
2019
Q2 		$10K Buy
35
+3
+9% +$739 ﹤0.01% 647
2019
Q1 		$7K Hold
32
– – ﹤0.01% 732
2018
Q4 		$6K Buy
32
+29
+967% +$5.95K ﹤0.01% 368
2018
Q3 		$1K Buy
+3
New +$728 ﹤0.01% 743
2018
Q2 		– Sell
-1,099
Closed -$210K – 558
2018
Q1 		$210K Buy
1,099
+75
+7% +$13.8K 0.05% 132
2017
Q4 		$160K Sell
1,024
-16
-2% -$2.52K 0.03% 182
2017
Q3 		$162K Buy
+1,040
New +$164K 0.02% 305

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Zions Bancorporation's IDXX Position: Q4 2024 in Review

Zions Bancorporation held its Idexx Laboratories (IDXX) position steady in Q4 2024 at 63 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Zions Bancorporation first reported a position in IDXX in Q3 2017 and has held it in 29 quarters since. The position peaked at $349K in Q4 2022. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Zions Bancorporation held 63 shares of Idexx Laboratories worth $26K as of Q4 2024.
  • Zions Bancorporation left its Idexx Laboratories share count unchanged in Q4 2024.
  • Idexx Laboratories made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #477 holding.
  • Zions Bancorporation first reported a position in Idexx Laboratories in Q3 2017 and has held it in 29 quarters since.
  • Zions Bancorporation's Idexx Laboratories position peaked at $349K in Q4 2022.
  • 1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.